Loading...

AROA  

San Diego,  CA 
United States
http://www.aroa.com
  • Booth: 414


Endoform is an advanced ECM available for use from day one.

Kickstart care of acute & chronic wounds

The only ECM available for professional use from day one.

Endoform is a unique extracellular matrix (ECM) that supports all phases of wound healing. Simple, easy to use and can also be applied by a nurse. Endoform provides a natural, porous bioscaffold to help build new tissue. Endoform is appropriate for use early in wound management to escape the inflammatory phase and advance healing to the proliferative phase.

Endoform Natural and Endoform Antimicrobial are indicated for the management of acute and chronic wounds including:

  • Partial and full thickness wounds
  • Pressure ulcers
  • Venous ulcers
  • Diabetic ulcers
  • Chronic vascular ulcers
  • Tunneled/undermined wounds
  • Surgical wounds (donor sites, grafts, post Moh’s surgery, post laser surgery, podiatric, wound dehiscence)
  • Traumatic wounds (abrasions, lacerations, second-degree burns, and skin tears)
  • Draining wounds

Endoform can be used in conjunction with negative pressure wound therapy (NPWT) and compression therapy.

Visit www.aroa.com for more information and downloads

Brands: Endoform is available in Natural and Antimicrobial formats (0.3% ionic silver). It is also available across a range of sizes to suit your application.


 Products

  • Endoform Natural™
    Endoform™ Natural Restorative Bioscaffold is a unique ECM for the management of acute and chronic wounds. Endoform™ supports all phases of wound healing and is appropriate for use early in wound management to restore protease balance....

  • Endoform™ Natural is a natural restorative bioscaffold extracellular matrix which; 

    • Provides a natural porous ECM bioscaffold for rapid cell infiltration
    • Contains more than 150 ECM proteins known to be important in wound healing
    • Contains residual vascular channels to support the establishment of new vasculature
    • Can indicate the presence or absence of proteases and help restore protease balance and guide re-application
    • Can be used by any wound care provider from day one

    Endoform™ Natural Restorative Bioscaffold products is indicated for the management of acute and chronic wounds including:

    • Partial and full thickness wounds
    • Pressure ulcers
    • Venous ulcers
    • Diabetic ulcers
    • Chronic vascular ulcers
    • Tunneled/undermined wounds
    • Surgical wounds (donor sites, grafts, post Moh’s surgery, post laser surgery, podiatric, wound dehiscence)
    • Traumatic wounds (abrasions, lacerations, second-degree burns, and skin tears)
    • Draining wounds
       

    More information available https://aroa.com/product/endoform/

  • Endoform™ Antimicrobial
    Endoform™ Antimicrobial Restorative Bioscaffold is a unique extracellular matrix (ECM) products for the management of acute and chronic wounds where there is elevated risk of infection....

  • Endoform™ Antimicrobial Restorative Bioscaffold contains 0.3% ionic silver, appropriate for use in early acute and chronic wound management where there is an elevated risk of infection.

    • Provides broad spectrum antimicrobial activity for up to 7 days*
    • Prevents biofilm formation
    • Is non-cytotoxic to dermal cells

    Endoform products:

    • Provide a natural porous ECM bioscaffold for rapid cell infiltration
    • Contain more than 150 ECM proteins known to be important in wound healing
    • Contain residual vascular channels to support the establishment of new vasculature
    • Can indicate the presence or absence of proteases and help restore protease balance and guide re-application
    • Can be used by any wound care provider from day one

    *Endoform™ Antimicrobial contains 0.3% ionic silver to protect the dressing from microbial colonization

    For more information visit https://aroa.com/product/endoform/

    Ionic silver have been included in the Endoform™ Antimicrobial to protect the device from microbial contamination. Reduction in colonization or microbial growth on the device has not been shown to correlate with a reduction in infections in patients. Clinical studies to evaluate reduction in infection have not been performed.